Oral induction therapy with obefazimod (Abivax) for 8 weeks led to clinically meaningful improvements across all efficacy endpoints in a highly refractory population of patients with moderately to ...
ECCO 2025 Subcutaneous Guselkumab Proves Efficacious for IBD For both induction and maintenance therapy, subcutaneous guselkumab significantly improves clinical outcomes in patients with ulcerative ...
Health Maintenance in Ulcerative Colitis: 5 Things to Know Drs Sandra Naffouj and Emanuelle Bellaguarda outline key tips for maintaining health in patients with ulcerative colitis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results